Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 4/20 | 0.64 |
| ▸ | HPGD | P15428 | 2/20 | 0.64 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.64 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.60 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.60 |
| ▸ | HTT | P42858 | 4/20 | 0.57 |
| ▸ | MAPT | P10636 | 2/20 | 0.57 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.57 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.57 |
| ▸ | NCF1 | P14598 | 2/20 | 0.56 |
| ▸ | GAA | P10253 | 2/20 | 0.56 |
| ▸ | TSHR | P16473 | 2/20 | 0.56 |
| ▸ | TP53 | P04637 | 1/20 | 0.56 |
| ▸ | NQO2 | P16083 | 1/20 | 0.52 |
| ▸ | POLB | P06746 | 1/20 | 0.52 |
| ▸ | MEN1 | O00255 | 1/20 | 0.51 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.51 |
| ▸ | SLC2A1 | P11166 | 1/20 | 0.51 |
| ▸ | NPC1 | O15118 | 1/20 | 0.49 |
| ▸ | IGF1R | P08069 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29877118 | 1.00 | LMNA (0.64) | LMNAHPGDSMN1; SMN2CYP1A2ALOX15 | |
| SCHEMBL25490903 | 0.83 | NCF1 (0.59) | LMNAHPGDSMN1; SMN2CYP1A2HTT | |
| SCHEMBL3975907 | 0.83 | CYP1A2 (0.58) | LMNAHPGDSMN1; SMN2CYP1A2HTT | |
| SCHEMBL7532440 | 0.81 | CYP1A2 (0.56) | LMNAHPGDSMN1; SMN2CYP1A2HTT | |
| SCHEMBL30065410 | 0.81 | HPGD (0.64) | LMNAHPGDSMN1; SMN2ALOX15HTT | |
| SCHEMBL396614 | 0.81 | HPGD (0.64) | LMNAHPGDSMN1; SMN2ALOX15HTT | |
| SCHEMBL28010962 | 0.81 | LMNA (0.64) | LMNAHPGDSMN1; SMN2CYP1A2ALOX15 | |
| SCHEMBL423902 | 0.80 | CYP1A2 (0.55) | SMN1; SMN2CYP1A2NCF1GAATP53 | |
| SCHEMBL12283481 | 0.80 | NCF1 (0.56) | LMNASMN1; SMN2CYP1A2HTTNCF1 | |
| SCHEMBL9724306 | 0.79 | KDM4E (0.59) | LMNAHPGDSMN1; SMN2CYP1A2MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 127 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2119717-B1 | 8-[3-amino-piperidin-1-yl]-xanthins, their production and utilisation as DPP IV inhibitors | BOEHRINGER INGELHEIM INT (DE) | 2018-01-17 | — | — | EP | claimed |
| US-8697868-B2 | 8-[3-amino-piperidin-1-yl]-xanthines, their preparation and their use as pharmaceutical compositions | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2014-04-15 | — | — | US | claimed |
| US-20090137801-A1 | 8-[3-AMINO-PIPERIDIN-1-YL]-XANTHINES, THEIR PREPARATION AND THEIR USE AS PHARMACEUTICAL COMPOSITIONS | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2009-05-28 | — | — | US | claimed |
| EP-1758905-B1 | 8-[3-AMINO-PIPERIDIN-1-YL]-XANTHINE, THE PRODUCTION THEREOF AND THE USE IN THE FORM OF A DDP-IV INHIBITOR | BOEHRINGER INGELHEIM INT (DE) | 2009-04-29 | — | — | EP | claimed |
| US-20050234108-A1 | 8-[3-amino-piperidin-1-yl]-xanthines, their preparation and their use as pharmaceutical compositions | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2005-10-20 | — | — | US | claimed |
| EP-0065192-B1 | GROWTH-PROMOTING FODDER OR DRINKING LIQUID | BASF Aktiengesellschaft (DE) | 1984-02-01 | — | — | EP | claimed |
| CN-119285646-B | Benzofuran acridine photoelectric material and preparation method and application thereof | 烟台九目化学股份有限公司 | 2025-05-27 | — | — | CN | disclosed |
| CN-119285646-A | Benzofuran acridine photoelectric material and preparation method and application thereof | 烟台九目化学股份有限公司 | 2025-01-10 | — | — | CN | disclosed |
| US-20240218135-A1 | PROTECTIVE FILM AND LAMINATE | FUJIFILM CORPORATION (JP) | 2024-07-04 | — | — | US | disclosed |
| US-20240118611-A1 | TRANSFER FILM AND PHOTOSENSITIVE COMPOSITION | FUJIFILM CORPORATION (JP) | 2024-04-11 | — | — | US | disclosed |
| CN-117751328-A | Protective film and laminate | 富士胶片株式会社 | 2024-03-22 | — | — | CN | disclosed |
| CN-116982002-A | Transfer film and photosensitive composition | 富士胶片株式会社 | 2023-10-31 | — | — | CN | disclosed |
| CN-116888534-A | Transfer film, pattern forming method, circuit wiring manufacturing method, and touch panel manufacturing method | 富士胶片株式会社 | 2023-10-13 | — | — | CN | disclosed |
| US-4510146-A | SUBSTITUTED QUINOLINE COMPOUNDS | BASF AKTIENGESELLSCHAFT (DE) | 1985-04-09 | — | — | US | disclosed |
| EP-0124752-A1 | Mixtures of substances with growth and output accelerating effect as well as feed and watering liquids which contain low amounts of these mixtures | BASF Aktiengesellschaft (DE) | 1984-11-14 | — | — | EP | disclosed |
| EP-0065192-B1 | GROWTH-PROMOTING FODDER OR DRINKING LIQUID | BASF Aktiengesellschaft (DE) | 1984-02-01 | — | — | EP | disclosed |
| EP-0065192-A1 | Growth-promoting fodder or drinking liquid | BASF Aktiengesellschaft (DE) | 1982-11-24 | — | — | EP | disclosed |
| EP-0014929-B1 | DIAGNOSTIC MEANS, PROCESS FOR ITS PREPARATION AND ITS USE IN DETERMINING LEUCOCYTES IN BODY FLUIDS | Roche Diagnostics GmbH (DE) | 1982-01-06 | — | — | EP | disclosed |
| US-4299917-A | IMPREGNATION OF AN ABSORBENT CARRIER WITH A SULPHONPHTHALEIN ESTER AND AN ACTIVATOR | BOEHRINGER MANNEHEIM GMBH (DE) | 1981-11-10 | — | — | US | disclosed |
| EP-0014929-A1 | Diagnostic means, process for its preparation and its use in determining leucocytes in body fluids | Roche Diagnostics GmbH (DE) | 1980-09-03 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090137801-A1 | 8-[3-AMINO-PIPERIDIN-1-YL]-XANTHINES, THEIR PREPARATION AND THEIR USE AS PHARMACEUTICAL COMPOSITIONS | DPP8, DPP4, DPP7 | LMNA 2911/4885HPGD 2402/4885SMN1; SMN2 2069/4885 |
| US-20050234108-A1 | 8-[3-amino-piperidin-1-yl]-xanthines, their preparation and their use as pharmaceutical compositions | DPP8, DPP4, DPP7 | LMNA 1878/4885HPGD 2630/4885SMN1; SMN2 1725/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.